The U.S. Food and Drug Administration (FDA) is now working with the Department of Veterans’ Affairs, the National Institutes of Health (NIH), and the 3D printing trade group America Makes to provide some coherence and regulation to the work of additive companies and individuals to address the COVID-19 outbreak in the U.S.
The result is the COVID-19 Health Care Needs and Additive Manufacturing (AM) Capabilities Repository, an online library where AM companies can upload designs to be reviewed and placed on the NIH 3D Print Exchange. When uploaded through the America Makes submission form, 3D printable designs will be fast tracked for review. According to the organization, this approval process is meant to help determine the safety and reliability of these devices in a healthcare setting.
The site will include information necessary for AM and healthcare providers that will ensure they meet medical standards for production. Through this process, the FDA is processing Emergency Use Authorization Applications to streamline the availability of safe medical devices. So far on the NIH repository, two face shields are under clinical review, while numerous others are prototypes in progress. This raises the question of just how much innovation needs to be dedicated to face shields when there are already so many designs available. The next step for these shields is FDA Emergency Use Authorization.
Meanwhile, the VHA has established an ecosystem meant to connect hospitals and clinics within the VA healthcare system that have 3D printing design and engineering expertise so that they can provide that expertise to others. As a part of the VHA Innovation Ecosystem, lessons and resources can be shared with frontline employees and the 3D printing community. Individuals can also volunteer to print, design, or provide feedback for in-demand equipment & resources.
Within this larger effort, the FDA and its partners are establishing other resources to aid in the development, production and distribution of 3D-printed medical devices as well. This includes a key FAQ page on 3D printing medical devices, accessories and parts during the pandemic. Here is a summarized list of what is discussed on the page:
- The FDA has issued previous guidance on 3D printed medical devices that should be considered during the pandemic.
- 3D-printed personal protection equipment (PPE) will not provide the same protection as FDA-cleared surgical masks and N95 respirators, but if they are used, the FDA has provided information about how to make them as effective as possible.
- Safety considerations that should be taken into account for 3D printed masks include:
- checking the mask for seals
- ensuring that the wearer can breathe through the mask and any makeshift filters
- using caution in surgical environments
- knowing the mask may not be an adequate filter for preventing the transmission of disease
- safely disposing of the masks.
- Complex products cannot be easily printed
- Those printing parts should ensure they match originals as much as possible and ensure they fit and work properly.
- Those printing parts should work with relevant medical device manufacturers.
- The FDA is willing to discuss the possibility of 3D printing entire medical devices and should be contacted at [email protected] to learn more.
- The FDA’s Emergency Use Authorization (EUA) includes 3D printed tubing for multiplexing ventilator use.
Other critical information shared by the FDA includes studies examining and optimizing the decontamination and reuse of respirators during public health emergencies. Additionally, ASTM International is offering free access to its Standards related to COVID-19. The FDA has also provided a link to Cambridge University’s research into the efficacy of household materials as filters used during a flu pandemic.
We will examine all of this information in greater detail to better understand what is and isn’t needed from 3D printing providers to address medical supply shortages, as well as the safety precautions involved, and provide further updates in subsequent articles.
You May Also Like
To End Animal Testing, BICO & CCS Push FDA Modernization Act
As the world continues developing alternatives to animal testing like bioprinting, in vitro models of human tissues, and predictive computer models, the demand for live animal testing has become outdated...
India’s Primaeam Solutions Opens 3D Printing Service with Materialise
Primaeam Solutions Pvt Ltd, an additive manufacturing (AM) services has announced the opening of a new, 10,000 sq. ft. service bureau located in the firm’s home city of Chennai, the...
3D Printing News Briefs, January 5, 2022: Software, Research, & More
We’re kicking off today’s 3D Printing News Briefs with 3D software, as Materialise has integrated Siemens’ Parasolid with its own Magics software. Moving on, The Virtual Foundry launched a metal...
“World’s Largest Real Concrete 3D Printed Building” Goes up in Oman
COBOD’s additive construction technology has been deployed worldwide, from Germany to Kenya, the U.S. to Belgium. The latest location for the Danish firm’s construction 3D printer is Oman, where COBOD...
View our broad assortment of in house and third party products.